On the afternoon of February 20, the signing ceremony of the entrusted management agreement and key projects for the Guangdong-Macao Cooperative Traditional Chinese Medicine Science and Technology Industrial Park was held at the Guangdong-Macao Cooperative Traditional Chinese Medicine Science and Technology Industrial Park. Seventeen key projects, including Guangdong Provincial Laboratory of Traditional Chinese Medicine (referred to as "Hengqin Laboratory"), were signed.
Liu Liang, academician of the Chinese Academy of Engineering, professor of GZUCM, chief scientist of Guangdong Provincial Academy of Chinese Medicine, and director of the National Key Laboratory of Traditional Chinese Medicine Syndrome, as the representative of the "Guangdong Provincial Laboratory of Traditional Chinese Medicine", signed the project agreement with the representatives from the industrial park and Chairman of the Guangdong-Macao Cooperative Traditional Chinese Medicine Science and Technology Industrial Park Development Co., Ltd., Wu Song. The signing ceremony was attended by He Yicheng, Chief Executive of the Macao Special Administrative Region, Zheng Xincong, Director of the Liaison Office of the Central People's Government in the Macao Special Administrative Region, Yu Yanhong, Director of the National Administration of Traditional Chinese Medicine, Li Weinong, Secretary for Economy and Finance of the Macao Special Administrative Region and Director of the Administrative Committee of the Guangdong-Macao Deep Cooperation Zone in Hengqin, Huang Luqi, Vice Director of the National Administration of Traditional Chinese Medicine, Academician of the Chinese Academy of Engineering, and President of the China Academy of Chinese Medical Sciences, Nie Xinping, Director of the Hengqin Office of the Guangdong Provincial Government, Wang Wei, President of GZUCM, and Vice President Wang Hongbin, and Shi Qiaorong, Secretary of the CPC Committee of the Second Affiliated Hospital of GZUCM (Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medicine), participated in the ceremony as witnesses.
Hengqin Laboratory was established in the context of the national promotion of the construction of high-end technology support platforms for traditional Chinese medicine. Its establishment was driven and planned by the National Administration of Traditional Chinese Medicine and the Guangdong Provincial CPC Committee and Government. Officially launched on December 28, 2023, the laboratory is led by the Hengqin Guangdong-Macao Deep Cooperation Zone Executive Committee, and jointly built by the Zhuhai Municipal People's Government, GZUCM and Guangdong Provincial Academy of Chinese Medicine. The laboratory will bring strong innovative momentum to the centenary development of GZUCM and the Second Affiliated Hospital of GZUCM (Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medicine), and will effectively promote the construction of "Double First-Class" university, a high-level university, and the high-quality development of hospitals.
The laboratory adheres to the important principles of upholding the originality, innovation, and inheritance of traditional Chinese medicine, and insists on cooperative construction and open sharing. It focuses on key research tasks around four major strategic needs: original theories of traditional Chinese medicine, prevention and treatment of major diseases, development of new TCM drugs, and international technological competition. It covers five major research directions, including the development of products for human immune defense and biological security in TCM; the interpretation of TCM principles on syndrome differentiation and disease identification combined with diagnosis and treatment; the development of TCM diagnosis and treatment schemes for common major chronic diseases; the development of modern diagnosis and treatment equipment, and the creation of new types of TCM drugs. It is hoped that breakthroughs can be made in the standardization and modernization of clinical diagnosis and treatment in traditional Chinese medicine, the enhancement of clinical value and service of traditional Chinese medicine, and the advancement of the high-end traditional Chinese medicine industry, thus contributing to the high-quality development of traditional Chinese medicine industry in Guangdong and the country, and at the same time promoting Macao's economic diversification.
